Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study.

Journal Information

Full Title: Circ Cardiovasc Qual Outcomes

Abbreviation: Circ Cardiovasc Qual Outcomes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr Reynolds is a consultant to iRhythm, Medtronic, Edwards Lifesciences, and Sanofi; Data and Safety Monitoring Board (DSMB) member (Affera). Drs Stein and Sun are employees of CVS Health. Dr Hytopoulos is an employee of iRhythm. Dr Cohen reports research grant support from iRhythm, Medtronic, and Boston Scientific; consulting income from Medtronic and Boston Scientific. Dr Steinhubl is an employee of physIQ and reports research funding from Janssen."

Evidence found in paper:

"Sources of Funding The current study was supported by iRhythm (San Francisco, CA). The original mSToPS trial (mHealth Screening to Prevent Strokes) was funded through a research grant from Janssen Pharmaceuticals to the Scripps Research Translational Institute. Additional support was provided through the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences grant UL1TR002550."

Evidence found in paper:

"REGISTRATION:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02506244."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025